Event-Driven Stocks

Organogenesis Holdings Inc.

ORGONasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 4 good● 1 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$564.2M$482.0M$433.1M$450.9M$468.1M$338.3M
Operating income$44.7M−$1.3M$12.5M$22.3M$72.9M$26.7M
Net income$37.0M$861,000$4.9M$15.5M$94.9M$17.2M
Total assets$598.7M$497.9M$460.0M$449.4M$443.3M$290.2M
Total liabilities$164.8M$112.6M$181.4M$183.7M$201.2M$148.4M
Equity$300.1M$262.9M$278.7M$265.7M$242.0M$141.8M
EPS (diluted)$0.15$-0.01$0.04$0.12$0.71$0.15
Shares out.126.8M132.0M131.2M128.8M128.0M105.4M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
7.9%
Net margin
6.6%
Return on equity
12.3%
Return on assets
6.2%
Return on capital (ROCE)
9.0%
Liabilities / assets
27.5%
Debt / equity
0.55×
Book value / share
$2.37
Revenue growth (YoY)
17.0%
Net income growth (YoY)
4201.0%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
5.27safe
Accruals / assets
7.9%moderate
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
80
/ 100
Profitability 100Growth 100Catalyst 67Earnings quality 33Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 1 warning● 4 good
  • Negative operating cash flow
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202616.2M8.5+2.3%
Apr 30, 202615.9M14.3+21.0%
Apr 15, 202613.1M3.8+2.4%
Mar 31, 202612.8M23.7+1.6%
Mar 13, 202612.6M14.4-0.2%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.